Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for early cancer detection. This investment increases OXcan's total funding to ...
Earlier this week, as hurricane-strength winds blew through bone-dry hillside subdivisions, Los Angeles saw its worst ...